Furthermore, the VMT captures drug responses dependent on tumor-stroma interactions, as seen by the effectiveness of the TGF-βR1 inhibitor galunisertib on SMAD4 mutant SW480 VMT growth, a result that is not seen in monolayer or spheroid cultures.15 The gene discussed is SMAD4; the disease is neoplasm.